Table A3.
Side Effect | Incidence of Side Effects: Risk Ratio (95% CI) | Incidence of Side Effects: Multivariate Logistic Regression, Coefficient (p-Value) | Severity of Side Effects: Univariate Cumulative Risk Models (p-Value) | Severity of Side Effects: Multivariate Cumulative Risk Models (p-Value) |
---|---|---|---|---|
Any side effect | 1.09 (1.05–1.12) | 0.581 (0.015) | <0.001 | 0.004 |
Localized reaction | 1.11 (1.06–1.16) | 0.411 (0.019) | 0.002 | NS |
Fever | 2.45 (2.01–3) | 0.902 (<0.001) | NS | NS |
Flu-like illness | 1.92 (1.61–2.29) | 0.691 (<0.001) | NS | NS |
Shortness of breath | 2.06 (1.22–3.49) | 0.564 (0.043) | NS | NS |
Skin rash | 1.38 (0.7–2.71) | NS | NS | NS |
Tingling | 1.22 (0.75–1.98) | NS | NS | NS |
Swelling | 0.73 (0.16–3.28) | NS | NS | NS |
Generalized swelling | 1.72 (0.8–3.73) | NS | NS | NS |
Anaphylaxis | 0.8 (0.09–6.85) | NS | NS | NS |
Fatigue or tiredness | 1.39 (1.24–1.56) | 0.459 (<0.001) | <0.001 | 0.002 |
Other | 1.45 (1.12–1.87) | 0.288 (0.069) | NS | NS |
Worse outcomes associated with a prior COVID-19 infection |